Seeking To Redefine What Is Possible® Promentis Pharmaceuticals, Inc., is a privately held biopharmaceutical company focused on the discovery and development of first-in-class therapies to treat central nervous system (CNS) disorders. Promentis’ drug development program is focused on activating a unique target known to restore glutamatergic neurotransmission and imbalances in oxidative stress, key contributors to impaired cortical function linked to multiple CNS disorders. The Company’s lead compound, SXC-2023, is being developed to treat various psychiatric disorders, with an initial focus on an indication that, despite representing a common disorder affecting millions of patients, has no FDA-approved treatment and a high level of patient need.
View Top Employees from Promentis Pharmaceuticals, Inc.Website | http://www.promentispharma.com |
Revenue | $10 million |
Funding | $64.8 million |
Employees | 4 (1 on RocketReach) |
Founded | 2007 |
Address | 826 N Plankinton Ave Ste 400, Milwaukee, Wisconsin 53203, US |
Phone | (414) 238-2992 |
Technologies |
JavaScript,
HTML,
PHP
+12 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Drug Stores & Pharmacies, Biotechnology, Retail, Science and Engineering, Medical, Health Care, Pharmaceutical |
Competitors | AcelRx Pharmaceuticals, Adamas Pharmaceuticals, Inc., Alexza / Ferrer, BIONOMICS LIMITED, Cerecin |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies |
Looking for a particular Promentis Pharmaceuticals, Inc. employee's phone or email?
The Promentis Pharmaceuticals, Inc. annual revenue was $10 million in 2024.
1 people are employed at Promentis Pharmaceuticals, Inc..
Promentis Pharmaceuticals, Inc. is based in Milwaukee, Wisconsin.
The NAICS codes for Promentis Pharmaceuticals, Inc. are [325, 3254, 32541, 32].
The SIC codes for Promentis Pharmaceuticals, Inc. are [283, 28].